Voice: Clinical Trials

16 trials of Voice, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 not yet recruiting, 1 terminated, 1 unknown. 9 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 6, Not yet recruiting 2, Terminated 1
Early Phase 11Completed 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow Voice: new trials by email Literature Review of Voice trials Research Report on Voice

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Virtual Outreach and Individualized Coaching Extension
Virtual Outreach and Individualized Coaching Extension - Chronic Disease, Mild Cognitive Impairment
Not applicableNot yet recruitingEmory University502026-10-012026-09-23
The Effect of Auditory Stimulation and the "Love Glove" Technique
Voice of a patient's relative, Voice of nurse, Love glove - Unconscious State
Not applicableNot yet recruitingManisa Celal Bayar University1002026-06-012026-05-22
Feasibility of Elder Mistreatment VOICES-CI Screening Tool
Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) - Elder Abuse, Elder Mistreatment
Not applicableCompletedYale University1022022-02-012023-09-22
Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)
Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) - Elder Abuse
Phase 1CompletedYale University802021-12-172023-07-17
The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote
mind. body. voice - Eating Disorders in Adolescence
Not applicableCompletedUniversity of Colorado, Boulder1702020-10-092023-05-17
Response of Preterm Infants to Multisensory Stimuli
Voice alone, Voice + tactile stimuli - Mother-Infant Interaction
Not applicableTerminatedUniversity Hospital, Geneva282020-09-012023-05-10
Virtual cOaching in Making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) - Elder Abuse
Early Phase 1CompletedYale University10122020-07-202023-04-20
Speech, Linguistic and Acoustic Markers in Parkinson's Disease
Cognitive Battery, Voice, Speech and Language Analysis, Questionnaires and Clinical Assessments - Parkinson Disease, Cognitive Impairment, Mild
CompletedUniversity of Massachusetts, Worcester582020-01-132025-06-10
Project VOICE: Vascular Outcomes Improvement Through Collection of PatiEnt Reported Data
VOICE/Fitbit, Daily self-reported exercise adherence - Peripheral Artery Disease
Not applicableCompletedUniversity of Michigan282018-08-022019-11-29
Description and Modeling of Swallowing Disorders After a Stroke
Neurological evaluation, Laryngological evaluation, MRI evaluation - Stroke, Swallowing Disorders
UnknownUniversity Hospital, Grenoble1502016-08-012017-07-17
Voices for Food: Food Policy Councils, Food Security and Healthy Food Choices
Coaching and Voices for Food Kit, Voices for Food Kit - Food Security, Nutritive Value
Not applicableCompletedSouth Dakota State University17352014-08-012018-06-21
Improving Care and Reducing Cost Study
Relapse Prevention Plan, Daily Support Website, Computer CBT for voices and paranoia - Schizophrenia, Schizoaffective Disorder
Not applicableCompletedNorthwell Health4612013-04-012017-03-23
Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery
Voice and Swallowing evaluations - Dysphagia, Dysphonia
CompletedUniversity of Alabama at Birmingham2002009-10-262026-01-16
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%
More frequent than normal office visits, Electronic reminders (voice, e-mail, text messages), Parenteral involvement / intervention reminders - Acne
Phase 4CompletedGalderma R&D612006-06-012022-07-29
Efficacy of Voice Treatment for Parkinson's Disease
Voice/Respiration Treatment, Speech/Articulation Treatment - Parkinson's Disease, Dysphagia
Not applicableCompletedUniversity of Colorado, Boulder6202002-03-012018-07-31
Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR
VOICES/VOCES, Standard STD clinic services - Sexually Transmitted Diseases
Phase 2 / Phase 3CompletedCenters for Disease Control and Prevention36602001-07-012008-06-05

Conditions studied

Deglutition Disorders (3)  ·  Cognitive Dysfunction (2)  ·  Parkinson Disease (2)  ·  Speech (2)  ·  Acne Vulgaris (1)  ·  Chronic Disease (1)  ·  Dysarthria (1)  ·  Dysphonia (1)  ·  Intermittent Claudication (1)  ·  Mental Disorders (1)  ·  Peripheral Arterial Disease (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Sexually Transmitted Diseases (1)  ·  Stroke (1)

Sponsors

Yale University (3)  ·  University of Colorado, Boulder (2)  ·  Centers for Disease Control and Prevention (1)  ·  Emory University (1)  ·  Galderma R&D (1)  ·  Manisa Celal Bayar University (1)  ·  Northwell Health (1)  ·  South Dakota State University (1)  ·  University Hospital, Geneva (1)  ·  University Hospital, Grenoble (1)  ·  University of Alabama at Birmingham (1)  ·  University of Massachusetts, Worcester (1)  ·  University of Michigan (1)

Countries

United States (12)  ·  France (1)  ·  Puerto Rico (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Fuad Abujarad, PhD,MSc (3)  ·  Dan Remley, PhD (1)  ·  Donna Mehrle, MPH, RD, LD (1)  ·  Heather Eicher- Miller, PhD (1)  ·  Jane Chung, PhD, RN (1)  ·  John Kane (1)  ·  Kara Smith, MD (1)  ·  Lisa Franzen-Castle, PhD (1)  ·  Lorraine Ramig, PhD, CCC-SLP (1)  ·  Lydia O'Donnell, Ed.D. (1)  ·  Matthew A. Corriere, M.D. (1)  ·  Rebecca Henne, MS (1)  ·  Ronald W Gottschalk, MD (1)  ·  Suzanne Stluka, PhD, RD, LN (1)  ·  William R Carroll, MD (1)

Results publications

PMID 30139336, PMID 31711170, PMID 32639484, PMID 32703690, PMID 33350943, PMID 42635253

NIH funding

R01AG060084 (3), K23DC016656 (1), R01DC001150 (1)